Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cost Effectiveness Analysis Of Using Beta-3 Agonists Over Anticholinergics For Treatment Of Overactive Bladder In Reducing Risk And Cost Of Anticholinergic-Associated Cognitive Decline.
Journal: Urology practice
Published: August 28, 2026
Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive Bladder.
Journal: Neurourology and urodynamics
Published: March 16, 2025
Cost Analysis of Oral Phenazopyridine vs Intravesical Lidocaine for Preprocedural Analgesia for Intradetrusor OnabotulinumtoxinA Injections.
Journal: Urology practice
Published: June 24, 2024
Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator.
Journal: Neurourology and urodynamics
Published: October 05, 2023
An analysis of factors that influence patient preference of third-line therapy for overactive bladder.
Journal: Neurourology and urodynamics
Published: July 13, 2022
Initial experience using the Axonics sacral neuromodulation system in patients with multiple sclerosis.
Journal: Neurourology and urodynamics
Published: November 01, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026